Advanced in Corpus Callosum Dysgenesis Hypopituitarism

Mona A. Massoud

Hospices Civils De Lyon, Groupement Hospitalier Est, 
Lyon, FR 
Advanced in Corpus Callosum Dysgenesis Hypopituitarism
Hospices Civils De Lyon, Groupement Hospitalier Est, 
Lyon, FR 
OverviewLocationsClinical Research

Overview

Mona Massoud practices in Lyon, France. Ms. Massoud is rated as an Advanced expert by MediFind in the treatment of Corpus Callosum Dysgenesis Hypopituitarism. Her top areas of expertise are Fetal Enterovirus Syndrome, Polyhydramnios, Cerebellar Hypoplasia, and Corpus Callosum Dysgenesis Hypopituitarism.

Her clinical research consists of co-authoring 63 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Corpus Callosum Dysgenesis Hypopituitarism.

Gender
Female

Locations

Hospices Civils De Lyon, Groupement Hospitalier Est, Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Descriptive, Prospective, Multi-country, Multicentre Study to Assess Performance of Genital Herpes Simplex Virus-2 (HSV-2) Related Disease Endpoints Based on Patient-reported Health Outcomes, Self-swabbing Collected Via Decentralised Approach in Patients ≥ 18 Years of Age in the United States and Europe.
A Descriptive, Prospective, Multi-country, Multicentre Study to Assess Performance of Genital Herpes Simplex Virus-2 (HSV-2) Related Disease Endpoints Based on Patient-reported Health Outcomes, Self-swabbing Collected Via Decentralised Approach in Patients ≥ 18 Years of Age in the United States and Europe.
Enrollment Status: Completed
Publish Date: March 07, 2025
Intervention Type: Procedure
A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
Enrollment Status: Terminated
Publish Date: February 20, 2025
Intervention Type: Biological, Drug
Study Drug: RSV Maternal vaccine
Study Phase: Phase 3
Assessment of Post-traumatic Stress Disorder (PTSD) in Patients Monitored for Cytomegalovirus (CMV) Seroconversion During Pregnancy, Without Ultrasound Signs or With Non-serious Ultrasound Signs of Maternal-fetal CMV Infection.
Assessment of Post-traumatic Stress Disorder (PTSD) in Patients Monitored for Cytomegalovirus (CMV) Seroconversion During Pregnancy, Without Ultrasound Signs or With Non-serious Ultrasound Signs of Maternal-fetal CMV Infection.
Enrollment Status: Completed
Publish Date: February 28, 2024
Intervention Type: Other
Antenatal Diagnosis of Coarctations of the Aorta. Prospective Observational Study.
Antenatal Diagnosis of Coarctations of the Aorta. Prospective Observational Study.
Enrollment Status: Completed
Publish Date: May 14, 2019
Intervention Type: Diagnostic test
View 3 Less Clinical Trials

63 Total Publications

Epidemiological changes in Toxoplasma infection: a 7-year longitudinal study in pregnant women in Lyon, France, 2017-2023.
Epidemiological changes in Toxoplasma infection: a 7-year longitudinal study in pregnant women in Lyon, France, 2017-2023.
Journal: Parasite (Paris, France)
Published: March 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Massoud's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 32 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile